Related Experiment Video
Updated: Feb 7, 2026

Rapid and Robust Analysis of Cellular and Molecular Polarization Induced by Chemokine Signaling
Published on: December 12, 2014
Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms
Alexandra M Thomas1, Ronald S Duman1
1Department of Psychiatry, Yale University, New Haven, CT 06508, U.S.A.
Abstract:
Depression is a chronic, debilitating, and common illness. Currently available pharmacotherapies can be helpful but have several major drawbacks, including substantial rates of low or no response and a long therapeutic time lag. In pursuit of better treatment options, recent research has focussed on rapid-acting antidepressants, including the N-methyl-D-aspartate (NMDA) receptor (NMDAR) antagonist ketamine, which affects a range of signaling pathways in ways that are distinct from the mechanisms of typical antidepressants. Because ketamine and similar drugs hold the promise of dramatically improving treatment options for depressed patients, there has been considerable interest in developing new ways to understand how these compounds affect the brain. Here, we review the current understanding of how rapid-acting antidepressants function, including their effects on neuronal signaling pathways and neural circuits, and the research techniques being used to address these questions.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Antidepressant Drugs: Overview
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
Antidepressant Drugs: MAOIs and Other Agents
Molecular Chaperones and Protein Folding
The...
Mechanical Protein Functions

